Cellebrite DI Ltd
NASDAQ:CLBT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.04
22.52
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cellebrite DI Ltd
Wall Street
Price Targets
CLBT Price Targets Summary
Cellebrite DI Ltd
According to Wall Street analysts, the average 1-year price target for
CLBT
is 22.88 USD
with a low forecast of 21.21 USD and a high forecast of 25.2 USD.
CLBT Last Price Targets
Cellebrite DI Ltd
The latest public price target was made on Oct 23, 2024 by
Tomer Zilberman
from
Bank of America Securities
,
who expects
CLBT
stock to
drop by 11%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Tomer Zilberman
Bank of America Securities
|
20
USD
Downside 11% |
1 month ago
Oct 23, 2024
|
Cellebrite price target raised to $20 from $17 at BofA
TheFly
|
|
Jeff Van Rhee
Craig-Hallum
|
23
USD
Upside 2% |
2 months ago
Sep 25, 2024
|
Cellebrite price target raised to $23 from $20 at Craig-Hallum
TheFly
|
Eric Martinuzzi
Loop Capital Markets
|
17
USD
Downside 25% |
4 months ago
Aug 16, 2024
|
Cellebrite (CLBT) PT Raised to $17 at Lake Street Capital Markets
StreetInsider
|
|
Tomer Zilberman
Bank of America Securities
|
17
USD
Downside 25% |
4 months ago
Aug 16, 2024
|
Cellebrite price target raised to $17 from $13 at BofA
TheFly
|
|
Jeff Van Rhee
Craig-Hallum
|
16
USD
Downside 29% |
8 months ago
Apr 1, 2024
|
Cellebrite price target raised to $16 from $14 at Craig-Hallum
TheFly
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLBT's stock price target?
Price Target
22.88
USD
According to Wall Street analysts, the average 1-year price target for
CLBT
is 22.88 USD
with a low forecast of 21.21 USD and a high forecast of 25.2 USD.
What is Cellebrite DI Ltd's Revenue forecast?
Projected CAGR
17%
For the last 3 years the
compound annual growth rate for
Cellebrite DI Ltd's revenue is
19%.
The projected
CAGR
for the next 4 years is
17%.
What is Cellebrite DI Ltd's Operating Income forecast?
Projected CAGR
43%
For the last 3 years the
compound annual growth rate for
Cellebrite DI Ltd's operating income is
53%.
The projected
CAGR
for the next 4 years is
43%.
You don't have any saved screeners yet
